2016
DOI: 10.1002/ccr3.736
|View full text |Cite
|
Sign up to set email alerts
|

Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment

Abstract: Key Clinical MessageAfter ingesting a dose of baclofen thought to be lethal, a patient with severe neurologic signs was successfully managed despite initially being refractory to treatment. Patients with persistent neurologic abnormalities may still have an excellent prognosis despite lack of initial response. Additionally, we present a potential case of benzodiazepine withdrawal.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(8 citation statements)
references
References 25 publications
0
4
0
Order By: Relevance
“…In an already neurologically impaired patient, gastric decontamination is largely ineffective and possibly dangerous. Once absorption from the gastrointestinal tract has occurred, intravenous lipid therapy has been used with the aim of binding the circulating baclofen (Fox & Daly, 2016 ). The symptomatic treatment of neurological signs includes seizure control and mechanical ventilation to manage the comatose patients (Dias et al., 2011 ; Torre et al., 2008 ).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…In an already neurologically impaired patient, gastric decontamination is largely ineffective and possibly dangerous. Once absorption from the gastrointestinal tract has occurred, intravenous lipid therapy has been used with the aim of binding the circulating baclofen (Fox & Daly, 2016 ). The symptomatic treatment of neurological signs includes seizure control and mechanical ventilation to manage the comatose patients (Dias et al., 2011 ; Torre et al., 2008 ).…”
Section: Discussionmentioning
confidence: 99%
“…The use of extracorporeal therapy has already been described as a strategy to actively remove absorbed baclofen and decrease the duration of intoxication in both human and veterinary medicine (Bates et al., 2013 ; Dias et al., 2011 ; Fox & Daly, 2016 ; Khorzad et al., 2012 ; Scott et al., 2007 ; Torre et al., 2008 ; Wismer, 2004 ; Wu et al., 2005 ). Although baclofen pharmacokinetics is not well established in dogs, the low protein binding (31%), low molecular weight (213 Da) and moderate volume of distribution (in humans 2.5 l/kg) suggest that baclofen is a suitable drug for removal by HD (Faigle & Keberle, 1972 ; Scott et al., 2007 ; Wu et al., 2005 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Baclofen is first renally excreted, with only a small portion (15%) being metabolized by the liver. Small amounts of baclofen can cross the blood-brain barrier at therapeutic doses; however, significant drug concentrations can accumulate within the cerebrospinal fluid at higher doses, leading to coma and respiratory depression 3 . Baclofen is available in 10 and 20 mg tablets and as a parenteral injection.…”
Section: Introductionmentioning
confidence: 99%